Dr Carole Helissey
- Specialty
- Medical oncologist, lung, kidney, bladder and prostate expert - therapeutic innovations and clinical research, from phase i to phase iii
- Hospital
- Hôpital Paris Saint Joseph
- Latest articles
-
- Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOS-Unicancer QUALIOR randomized phase 2 study. (Jan 17, 2026)
- Gastrointestinal metastasis in prostate cancer and therapeutic implications: A case report. (Oct 15, 2025)
- Prevention and management of PARP inhibitor-related haematological toxicities in prostate cancer: French expert opinion using the Delphi method. (Sep 13, 2025)
- Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5. (May 15, 2025)
- Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A. (May 1, 2025)